Literature DB >> 22982895

Fibrin-associated large B-cell lymphoma: part of the spectrum of cardiac lymphomas.

Aaron M Gruver1, Michael A Huba, Ahmet Dogan, Eric D Hsi.   

Abstract

Cardiac lymphomas are rare, and the spectrum of pathologic features is not well defined. We encountered an unusual case of cardiac lymphoma residing within a presumed thrombus. To place such cases in context, we reviewed all cardiac lymphomas presenting to a large US cardiovascular medicine referral center during a 30-year period. A total of 14 cardiac lymphomas were identified, and these included 6 primary cardiac lymphomas (PCLs) and 8 lymphomas secondarily involving cardiac structures. Upon review, 3 of the PCLs were confirmed to be diffuse large B-cell lymphoma, not otherwise specified, involving the myocardium. The other 3 cases of PCL lacked myocardial invasion and showed lymphoma cells embedded in fibrin thrombus. Acute inflammation was not evident. These lymphomas presented in immunocompetent male individuals and involved either a prolapsed myxomatous mitral valve, a pseudomyxoma from the left atrium, or a thrombus arising in a synthetic aortic root graft. All 3 consisted of large atypical lymphocytes expressing a nongerminal center B-cell immunophenotype. Two cases were positive for Epstein-Barr virus (latency type III), but none demonstrated human herpes virus-8 latent nuclear antigen. No systemic disease was found at presentation or during follow-up. In our experience, fibrin-associated large B-cell lymphoma arising in the heart represents a substantial proportion of PCL. These lymphomas appear to represent an underrecognized variant of diffuse large B-cell lymphoma with favorable outcome. Further study is needed to understand their natural history.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22982895     DOI: 10.1097/PAS.0b013e31825d53b5

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  7 in total

1.  Indolent EBV-positive T-cell lymphoproliferative disorder arising in a chronic pericardial hematoma: the T-cell counterpart of fibrin-associated diffuse large B-cell lymphoma?

Authors:  Zhen Wang; Qixing Gong; Youcai Zhao; Hai Xu; Shimin Hu; Zhihong Zhang
Journal:  Haematologica       Date:  2020-05-15       Impact factor: 9.941

2.  Automatic lymphoma classification with sentence subgraph mining from pathology reports.

Authors:  Yuan Luo; Aliyah R Sohani; Ephraim P Hochberg; Peter Szolovits
Journal:  J Am Med Inform Assoc       Date:  2014-01-15       Impact factor: 4.497

3.  B-cell lymphomas with discordance between pathological features and clinical behavior.

Authors:  Laurence de Leval; Christiane Copie-Bergman; Andreas Rosenwald; Lisa Rimsza; Stefania Pittaluga; Bettina Bisig; Stefan Dirnhofer; Fabio Facchetti; Stefano Pileri; Falko Fend; Andrew Wotherspoon
Journal:  Virchows Arch       Date:  2017-06-01       Impact factor: 4.064

4.  EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report-Part 1.

Authors:  Yasodha Natkunam; John R Goodlad; Amy Chadburn; Daphne de Jong; Dita Gratzinger; John K C Chan; Jonathan Said; Elaine S Jaffe
Journal:  Am J Clin Pathol       Date:  2017-02-01       Impact factor: 2.493

Review 5.  EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts.

Authors:  Stefan D Dojcinov; Falko Fend; Leticia Quintanilla-Martinez
Journal:  Pathogens       Date:  2018-03-07

6.  Incidental Pathogenic Fibrin-Associated Diffuse Large B-cell Lymphoma Found During Aorto-Biiliac Bypass.

Authors:  Peter M Habib; Thomas Serena; Caitlin M Flynn; Aaron Hartkop; Elizabeth Wey; David Lang; Eugene Laveroni
Journal:  Cureus       Date:  2022-03-31

Review 7.  Fibrin-associated diffuse large B-cell lymphoma with plasmacytic differentiation: case report and literature review.

Authors:  Esther Moreno Moreno; Ana Ferrer-Gómez; Héctor Pian Arias; Irene García García; Mónica García-Cosío
Journal:  Diagn Pathol       Date:  2020-09-24       Impact factor: 2.644

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.